SCHEMBL15058261

SCHEMBL15058261

C=CCC1CCCC1=CC(=O)O

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 3/20 0.37
NOS2 P35228 3/20 0.37
CAMK2A Q9UQM7 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
FAAH O00519 1/20 0.34
CDC25A P30304 1/20 0.33
CDC25B P30305 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 1/20 0.33
NOS3 P29474 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15058260 1.00 NOS1 (0.37) NOS1NOS2CAMK2ACYP1A2CYP2D6
SCHEMBL15058972 0.95 NOS1 (0.39) NOS1NOS2CAMK2ACYP1A2CYP2D6
SCHEMBL15058973 0.95 NOS1 (0.39) NOS1NOS2CAMK2ACYP1A2CYP2D6
SCHEMBL10537802 0.80 CAMK2A (0.38) CAMK2ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL15058647 0.77 NOS1 (0.31) NOS1NOS2
SCHEMBL15058646 0.77 NOS1 (0.31) NOS1NOS2
SCHEMBL9813664 0.75 CAMK2A (0.37) CAMK2ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL1133545 0.74 NOS1 (0.52) NOS1NOS2NOS3
SCHEMBL15058282 0.73 NOS1 (0.33) NOS1NOS2NOS3
SCHEMBL15058284 0.73 NOS1 (0.33) NOS1NOS2NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2794564-B1 STRIGOLACTAM DERIVATIVES AS PLANT GROWTH REGULATING COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2016-02-24 EP disclosed
US-9131688-B2 Strigolactam derivatives as plant growth regulating compounds SYNGENTA PARTICIPATIONS AG (CH) 2015-09-15 US disclosed
US-9131688-B2 Strigolactam derivatives as plant growth regulating compounds SYNGENTA PARTICIPATIONS AG (CH) 2015-09-15 US disclosed
US-9131688-B2 Strigolactam derivatives as plant growth regulating compounds SYNGENTA PARTICIPATIONS AG (CH) 2015-09-15 US disclosed
US-20140336052-A1 STRIGOLACTAM DERIVATIVES AS PLANT GROWTH REGULATING COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2014-11-13 US disclosed
US-20140336052-A1 STRIGOLACTAM DERIVATIVES AS PLANT GROWTH REGULATING COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2014-11-13 US disclosed
US-20140336052-A1 STRIGOLACTAM DERIVATIVES AS PLANT GROWTH REGULATING COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2014-11-13 US disclosed
EP-2794564-A1 STRIGOLACTAM DERIVATIVES AS PLANT GROWTH REGULATING COMPOUNDS Syngenta Participations AG (CH) 2014-10-29 EP disclosed
WO-2013092430-A1 STRIGOLACTAM DERIVATIVES AS PLANT GROWTH REGULATING COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2013-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140336052-A1 STRIGOLACTAM DERIVATIVES AS PLANT GROWTH REGULATING COMPOUNDS AREG, GHITM, GRK6 NOS1 510/4885NOS2 762/4885CAMK2A 1679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.